Investor FAQs

In This Section


In November 2016, Novelion was launched through a merger transaction in which Aegerion Pharmaceuticals became an indirect, wholly-owned subsidiary of QLT Inc. In conjunction with the closing of the merger, QLT changed its name to Novelion Therapeutics Inc. 

Novelion Therapeutics’ common stock is traded on the NASDAQ Global Select Market and the Toronto Stock Exchange under the ticker symbol "NVLN.” 


887 Great Northern Way, Suite 250
Vancouver, BC V5T 4T5 

Novelion does not offer a direct stock purchase plan. Shares of the Company should be purchased through a broker.

Novelion does not currently pay dividends.

Computershare Shareholder Services
Toll Free:  800 368 5948
Toll: +1 (781) 575 4223
Shareholder correspondence should be mailed to:
P.O. BOX 30170
College Station, TX 77845-3170
Overnight correspondence should be sent to:
211 Quality Circle, Suite 210
College Station, TX 77842
Shareholder website
Shareholder online inquiries

To replace lost certificates, contact the transfer agent:, a free web tool for shareholders.

To change address, contact the transfer agent:, a free web tool for shareholders.

Novelion’s fiscal year is based on the calendar year.
First Quarter ends 3/31, Second Quarter ends 6/30, Third Quarter ends 9/30 and Fourth Quarter ends 12/31.

Please submit your question using the form below.

Contact Form
* Indicates required field